CorrlensCorrlens
Correlate

Correlation Analysis

Corpay, Inc. vs Eli Lilly & Co.

CPAY vs LLY

-0.135

Weak inverse

When one moves up, the other tends to move down.

CPAY logo

Corpay, Inc.

CPAY

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.

Market cap 20.3B · 11,800 employees

LLY logo

Eli Lilly & Co.

LLY

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap 828.2B · 50,000 employees

Mar 25, 2024 — Apr 7, 2026Daily510 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: CPAYGray: LLY36 of 510 points (sampled)

Who Moves First

CPAY leads LLY by 6 days

CPAY tends to move before LLY.

After testing 13 timing shifts, the strongest relationship was -0.235 (they moved in opposite directions).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.089

9 periods · Return correlation when both series rose

Both Falling

+0.445

10 periods · Return correlation when both series fell

Diverging

-0.640

16 periods · Return correlation when series moved apart

R-Squared

1.8%

Share of variance in one series explained by the other.

Trend Agreement

57.2%

How often both series moved in the same direction period-to-period.

Overlap Quality

510

Robust shared window — 510 usable pairs.

Significance

p < 0.01

95% CI: [-0.219, -0.048]

Scatter

XY Regression

241.1260280300320340360380400400.56717008009001,0001,1001,111Corpay, Inc.Eli Lilly & Co.Data pointsFit (r = -0.135)

Pipeline

Data quality details

Pipeline Summary

510 paired data points survived the daily window.

Raw input

510

1,254

Normalized

510

1,254

Prepared

510

1,254

Aligned

510

510

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

744

A: 0 / B: 744

Series A

CPAY logo

Corpay, Inc.

CPAY

Market cap 20.3B · 11,800 employees

Stock · 510 raw → 510 prepared

Series B

LLY logo

Eli Lilly & Co.

LLY

Market cap 828.2B · 50,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

19

Estimated crossover points between normalized spreads.

Slope

-0.4568

Linear regression slope.

Intercept

1001.0101

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-cpay-vs-stock-lly-daily